Novel solutions to improve human health, born at Lund University. Explore LU Ventures' Life Science portfolio.
Explore the full Life Science Portfolio
- Reccan Diagnostics - Early diagnosis, better prognosis for pancreatic cancer patients
- SAGA Diagnostics - Personalised cancer care guided by the tumor's DNA
- Dx4Life - increase the chances of pregnancy in IVF
- Mantis Photonics - New imaging technique for screening of Alzheimer Disease
- Asgard Therapeutics - Direct cell reprogramming technologies for cancer immunotherapy.
- Sinntaxis - Novel therapeutics to enhance recovery after stroke
- Abarceo - On a mission to reverse diabetes
- Apoglyx - New therapies for inflammatory diseases
- Mireca Medicine - Developing small molecules to treat a broad band of photoreceptor mutations.
- Minervax - Developing a novel vaccine candidate against Group B Streptococci (GBS)
- Strominnate Therapeutics - Aiming to treat diseases in the nervous system
- Cell Invent - a new way to find Alzheimer’s cures
- MedVasc - Novel instrument for a less painful and more cost-effective treatment of varicose veins
- UmanSense - Develops a stroke alarm that notifies relatives in case of a suspected stroke
- Suturion - Develops an instrument for suturing the abdominal wall after surgery
- Medbeat - Mobile ECG module for arrhythmia detection.
- Gedea Biotech - antibiotic-free treatment of bacterial vaginosis
- Stairway Medical - Medical device for open airway during sedation.
- CarpoNovum - a new generation of surgical instruments, used throughout cancer surgery in the colon and rectum.
- Trackpaw Scientific - Introducing a new way of monitoring preclinical studies
- Bionamic - Software for managing the process of biologic drug development.
- Saromics Biostructures - a new technique for testing pharmaceutical substances using 3D structure analysis.
- VivoProtect - Better greens using innovative bacterial strains
- DUG Foodtech - Alumni. Plant-based foods
Curious to invest or get involved?
Contact Christine Widstrand,
CEO LU Ventures
christine [dot] widstrand [at] innovation [dot] lu [dot] se (christine[dot]widstrand[at]innovation[dot]lu[dot]se)
+46 70 928 63 78